ADVERTISEMENT
search.svg

 

Press Releases

 

APhA Names Antonio Ciaccia Senior Advisor for Disruptive Innovation and Practice Transformation

The American Pharmacists Association (APhA) announced today that it has named Antonio Ciaccia, Chief Strategy Officer of 3 Axis Advisors, as APhA’s Senior Advisor for Disruptive Innovation and Practice Transformation. This addition will supercharge the association’s efforts to disrupt our broken payment models and drive the profession of pharmacy forward. Antonio begins his duties immediately.

APhA Announces Candidates for President-elect, Trustees and Honorary President

The American Pharmacists Association (APhA) today announced the slate of candidates for its Board of Trustees, President-elect and Honorary President. The elections for these positions will be held March 12–May 3, 2021.

The two candidates for President-elect for 2022–2023 are Valerie Prince of Odenville, AL, and Wendy Weber of Bellevue, NE. The two pairs nominated for election to serve 2022–2025 terms on the APhA Board of Trustees are: Vibhuti Arya of Brooklyn, NY, vs. Sean Jeffery of Branford, CT; and Stephen Carroll of Benton, AR, vs. Scott Tomerlin of Rockledge, FL. Mary L. Euler of Union Town, PA, is unopposed as the candidate for Honorary President.

Ballots for APhA’s upcoming Board of Trustees elections will be emailed to members on the afternoon of Friday, March 12, 2021, along with ballots for candidates for the executive committees and sections of the APhA Academy of Pharmacy Practice & Management (APhA–APPM) and the APhA Academy of Pharmaceutical Research & Science (APhA–APRS) and for the APhA–APPM Special Interest Groups (SIGs). Further election and candidate information will be available online at the APhA Election webpage no later than mid-January. 

American Pharmacists Association Comments on the Presidential Election

The following is a statement from Scott J. Knoer, MS, PharmD, FASHP, on the election for President of the United States.

“The American Pharmacists Association welcomes the opportunity to work with the next administration and the 117th Congress to continue recognizing pharmacists as medical experts providing patient care. Chief among these are efforts to secure pharmacist provider status for Medicare coverage, and advocating for fundamental payment reform for pharmacists’ services. 

American Pharmacists Association Begins Recruiting for New 2021 Executive Residency Program

The American Pharmacists Association (APhA) is expanding career opportunities for pharmacists by growing its portfolio of postgraduate training programs. Building on the success of the APhA Foundation Executive Fellowship in Association Management & Leadership, which is funded by the Knowlton Center for Pharmacist-Based Health Solutions and provides broad association management and executive training, APhA will also begin recruiting for a new 2021–2022 Executive Residency program.

“We’re instituting these new positions and growing this program for several reasons. First, we want to offer pharmacists opportunities to advance their careers and gain insights and prospects for leadership. At the same time, we are engaging pharmacists in the success of APhA’s strategies, with the current and future needs of the profession in mind,” said Scott J. Knoer, MS, PharmD, FASHP, APhA Executive Vice President and CEO.

American Pharmacists Association Applauds FDA’s List of Essential Medicines and Medical Countermeasures

The American Pharmacists Association (APhA) today applauded the U.S. Food and Drug Administration’s publication of a list of essential medicines, medical countermeasures, and critical inputs that are medically necessary to have available at all times in adequate amounts and dosage forms to serve patient needs. This is the first time FDA has published a list of this kind. FDA noted that this list is intended to ensure that the American public is protected against outbreaks of emerging infectious diseases, such as COVID-19, as well as chemical, biological, radiological and nuclear threats. 

RSS
First567810121314Last